Heparin has been used in flush solutions in attempts to prolong the patency of arterial and central venous pressure monitoring lines. Its use however is not without risks such as hypersensitivity reactions and heparin-induced thrombocytopenia. Recent studies suggest that non-heparinised solutions may be as effective in maintaining catheter patency. Our aim is to determine if there is any difference in maintaining patency of arterial and central venous pressure monitoring lines using normal saline as compared to heparinised saline.
INtrODUCtION
The use of heparinised saline in maintaining patency of arterial and central venous pressure monitoring line has been a widespread practice in the critical care units for years. Heparin, a naturally occurring anticoagulant that helps prevent clotting and is given to prevent and treat thrombosis, is recommended to prevent blood clots from forming on the tips of arterial and central line catheters. Only with patients who are contraindicated to use heparin, normal saline solution was used.
It was not until recent studies have shown that normal saline solution is as effective in maintaining patency of arterial and central venous pressure monitoring line that healthcare providers have considered maintaining patency of arterial and central venous pressure monitoring line using nonheparinised solution. Three randomised, double blind controlled trials [1] [2] [3] were done to evaluate the efficacy of heparinised and non-heparinised solutions for the maintenance of artery catheter patency and all concluded that there were no significant differences between heparinised and * Presented as a paper in the Young Investigator's Award (Nursing) category at the 18th SGH Annual Scientific Meeting held in Singapore from 17-18 April 2009. Proceedings of Singapore Healthcare  Volume 20  Number 3  2011 non-heparinised flush solutions for maintenance of catheter patency. Arterial waveforms were also not shown to be frequently dampened in the nonheparinised catheters but heparinised saline flush resulted in greater accuracy of blood pressure monitoring 2, 3 . Heparinised solution did not increase the duration of the catheters nor did it improve its functionality significantly. Instead, heparin sodium altered aPTT (activated partial thromboplastin time) significantly 1 . Besides evaluating arterial catheters, study 4 was also done to evaluate the central venous catheters and it was found that there was no significant difference between the non-heparin and heparin groups for flow problems and thrombotic catheter occlusions.
The use of non-heparinised solution will avoid patient exposure to heparin-associated risks such as hypersensitivity reactions, local tissue damage, iatrogenic haemorrhage and heparininduced thrombosis-thrombocytopenia (HITTS), hence increasing patient safety. Non-heparinised solution will also increase the accuracy of patient's coagulation profile enhancing patient management.
However, there were randomised, double blind controlled studies 5,6,7 that advocate heparinised saline flushes. The authors concluded that normal saline solution as flush solution was associated with increased frequency of catheter occlusion and malfunctions compared with heparinised saline solution.
In light of these inconsistent findings to date, further research is needed to determine the effectiveness of non-heparinised flush solutions in maintaining arterial catheters for the benefit of safer clinical practice.
Currently, our unit practises using heparinised saline solution in priming of arterial and central lines. Hence, if the outcome is positive, it is intended that normal saline solution will replace heparinised saline solution in maintaining the effectiveness of the arterial and central venous pressure monitoring line. By simplifying the priming procedure, nurses will have more time to provide other aspects of nursing care to patients. The cost for heparin used for heparinised solution is absorbed by the cost centre hence savings will result from unnecessary tests to monitor platelet counts, aPTT and treating the side effects of heparin.
Hence, our study aims to determine if there is any difference in maintaining effectiveness of arterial and central venous pressure monitoring line using normal saline compared to heparinised saline. The hypothesis tested in this study will be there is no difference in maintaining effectiveness of arterial and central venous catheter whether using normal saline or heparinised saline in 72 hours and 120 hours of cannulation.
MetHODOlOgy
This study had been reviewed and approved by Institutional Review Board. Anonymity and confidentiality were ensured for each subject.
Setting and Subject
This study took place in the neuroscience intensive care unit (NSICU) at the Singapore General Hospital in Singapore from August 2008 to February 2009. The target population was patients admitted into the NSICU during the data collection period who met the sample criteria and consented to participate in the study. All patients requiring arterial and/or central venous pressure monitoring line with platelets within 140 to 440 x 10 9 /L, aPTT within 9.2 to 11.2 seconds and PT (prothrombin time) within 27 to 36.1 seconds were eligible for entry. Exclusion criteria included allergy to heparin, those receiving anticoagulant, thrombolytic or platelet therapy and those who had a history of HITTS. In this study, power analysis was used to calculate the minimum sample size required to achieve 70% power and a 0.05% level of significance. The calculated sample size was 69 based on GPOWER. GPOWER version 2.0 was developed by Dr Franz Faul and Professor Edgar Erdfelder from Department of Psychology in Bonn University, Germany, to perform high precision statistical power analyses for statistical tests 8 .
Design
A randomised controlled trial was used. Patients were randomised to receive either normal saline flush or heparinised saline flush. Randomisation was accomplished by choosing for the patient a sealed envelope (prepared by someone not involved in the study) containing a card labelled eiher "normal saline" or "heparinised saline".
Intervention
Prior to the start of research, staff were given details of the research study. Only staff who passed the competency assessment for caring of arterial and central venous catheters primed the lines. This was a single-blind study whereby patients were not aware of which group they were allocated in. With respect to the concern about patient safety because knowledge about whether the patient was receiving heparin might be relevant to treating adverse events or other medical emergencies, it was concluded that staff should not be blinded. Moreover, the result of the study would not be affected. In all cases, arterial line insertion was done using a 20 gauge BD angiocath catheter and central venous line insertion was done using triple lumen polyurethane central venous catheter from Biosensors International. These cannulations were performed by trained medical personnel. After cannulations, the flush solution (normal saline or heparinised saline) was attached to the transducer via tubing. The transducer system was then connected to Siemens SC9000XL multiparameter monitor. In both groups, a continuous pressure of 300mmHg was applied with a pressure bag and a flow rate of 3ml/hr was maintained through a pressure monitoring kit with Accutrans disposable pressure transducer (Biosensors International, Singapore). At all times, the tubing remained free of blood clots and air bubbles. The transducer was also accurately zeroed at every shift. Data was collected at 8-hour intervals for up to 120 hours on presence of acceptable arterial waveform, arterial backflow and/or central venous backflow and recorded in the data collection form (see Fig. 1 ). reSUltS Seventy patients were recruited for this study and all completed the study with no drop-outs. Thirtysix were allocated into the normal saline group and 34 in the heparinised saline group. In the normal saline group, 24 of them had artery cannulation only while 12 of them had artery and central venous cannulation. The heparinised saline group had 12 artery cannulation only and 22 artery and central venous cannulation. The normal saline group consisted of 44% females and 56% males while the heparinised saline group had 35% females and 65% males. Chi square analysis showed that gender was not statistically different between groups (p=0.435). Radial artery was the most common site of cannulation followed by brachial artery and dorsalis pedis artery. In the normal saline group, 26 had radial artery cannulation and 10 had brachial artery cannulation. In the heparinised saline group, 28 had radial artery cannulation, 4 had brachial artery cannulation and 2 had dorsalis pedis artery cannulation. Chi square analysis demonstrated that sites of cannulation was not statistically different between groups (p=0.101). (See Table 1 
DISCUSSION
Using heparinised saline as the flush solution was the common practice in maintaining catheter effectiveness. However, safety and cost issues arose leading practitioners to question this practice. Over the years, there had been controversy over the type of flush solutions to maintain catheter effectiveness.
This study was designed to determine whether there was any difference in maintaining catheter effectiveness when using normal saline compared to heparinised saline as flush solutions. In our study, we found that there was no difference in maintaining catheter effectiveness whether using normal saline or heparinised saline as flush solution at 72 and 120 hours of cannulation (see Table 6 ).
Since the demographic characteristics for both groups were equivalent, any difference could be attributed to the type of flush solutions.
Though our findings were similar to Tuncali et al 3 whereby there was no significant difference between heparinised and non-heparinised flush solution for maintenance of artery catheter effectiveness, they explained that it was due to the short duration of cannulations. In their study, the mean duration of cannulations was as short as 6 to 7 hours while in our study, it was as long as 120 hours. Kulkarni et al 2 and Del Cotillo et al 1 did similar studies but with longer duration of cannulations at 96 hours and 5 days respectively. Both study findings were similar to the results of our study whereby there was no significant difference between heparinised saline and normal saline in maintaining artery catheter effectiveness. Hence, it could be concluded that it was the constant flush under pressure that maintained catheter effectiveness rather than use of heparinised saline solution. However, their studies could also have been inadequately powered to detect the differences 1-3 .
Kulkarni et al 2 reported that the use of heparinised saline flush resulted in greater accuracy of blood pressure monitoring. However our study findings differed. In our study, we found that as long as the arterial catheter was patent with the extraneous variables being controlled, the arterial waveform would be of good quality, neither overdampened nor underdampened therefore providing accurate blood pressure readings. Similarly, Tuncali et al 3 reported that arterial waveforms were not shown to be more frequently dampened in the nonheparinised catheters. Thus, arterial blood pressure monitoring could still be accurately performed whether using normal saline or heparinised saline as flush solutions.
Our study demonstrated no significant differences between heparinised saline solution and normal saline solution in maintaining central venous catheters. This finding was the same as Stephens et al 4 study whereby no statistically significant difference was found between the non-heparinised and heparinised groups for flow problem and thrombotic catheter occlusions in central venous catheters.
Generally, it was assumed that the widespread use of small doses of heparin was unlikely to cause any problems. However, in Ling et al 9 However there were limitations in this study. As this study took place only in the NSICU, results could not be generalised to the population. In this study, the duration of cannulation was measured in time intervals instead of actual hours. Therefore, the mean duration of cannulation in normal saline and heparinised saline groups could not be calculated.
Implications for Further research
Further studies could examine the maximum duration the invasive catheters could remain in place before complications occurred. This study could also be replicated using actual hours to measure duration of cannulation.
CONClUSION
Based on our study, we found that there was no significance difference between the 2 solutions used in the maintenance of patency for arterial and central venous catheters. Our findings support the elimination of using heparinised saline as flush solutions. This calls for a change in practice to provide safer therapy.
